Estados financieros detallados de Ensysce Biosciences, Inc. (ENSC): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 100.0%, margen operativo -10.9%, margen neto -10.8%.
Al precio actual de $0.45, ENSC presenta beneficios negativos (P/E no significativo) y un ROE del -316.63%. La capitalización bursátil es de $7M.
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | $1.8M | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | $1.6M | $3.4M | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | -$1.6M | -$1.6M | 0 | 0 | 0 | 0 | 0 | 0 |
| I+D | 0 | 0 | $3.4M | $4.4M | $4.7M | $19.8M | $7.6M | $7.2M | $10.4M |
| Generales y Administrativos | $146695 | 0 | $6.9M | $1.2M | $18.7M | $6.9M | $5.4M | $4.7M | $4.9M |
| Gastos Operativos | $146695 | -$600000 | $6.9M | $1.6M | $19.9M | $24.2M | $10.7M | $6.7M | $10.2M |
| Beneficio Operativo | -$147000 | -$959000 | -$8.6M | -$1.6M | -$19.9M | -$24.2M | -$10.7M | -$6.7M | -$10.2M |
| EBITDA | -$27555 | $2.7M | -$8.6M | -$1.6M | -$27.9M | -$24.1M | -$10.3M | -$6.7M | -$10.2M |
| Gastos por Intereses | 0 | 0 | 0 | $995496 | $1.3M | $109525 | $353945 | $1.3M | $18767 |
| Beneficio Antes de Impuestos | -$27558 | $2.7M | -$10.1M | -$160875 | -$29.1M | -$24.2M | -$10.6M | -$8.0M | -$10.2M |
| Impuestos | $3635 | $553916 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$31193 | -$1.3M | -$10.1M | $56770 | -$29.1M | -$24.2M | -$10.6M | -$8.0M | -$10.2M |
| BPA | $-0.01 | $-0.22 | $-1.66 | $0.56 | $-355.68 | $-139.44 | $-4.69 | $-4.57 | $-3.98 |
| BPA Diluido | $-0.01 | $-0.22 | $-1.66 | $0.56 | $-355.68 | $-139.44 | $-4.69 | $-4.57 | $-3.98 |
| Acciones en Circulación (Diluidas) | $6.0M | $6.0M | $6.1M | $6.4M | $84018 | $179932 | $2.3M | $1.7M | $25.6M |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $2.1M | $1.7M | $341536 | $194214 | $12.3M | $3.1M | $1.1M | $3.5M | $4.3M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | $170535 | $173552 | 0 | $441721 | $276821 | $97561 | $124115 | $420345 |
| Inventario | 0 | 0 | 0 | 0 | -$441721 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $2.3M | $1.9M | $618590 | $347876 | $15.7M | $5.3M | $2.3M | $5.3M | $7.2M |
| Inmovilizado Material | 0 | 0 | $351 | $151 | $24.72B | 0 | 0 | 0 | $124129 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $202.4M | $204.8M | $623941 | $351807 | $16.4M | $5.9M | $2.7M | $5.6M | $7.5M |
| Cuentas por Pagar | 0 | 0 | $540778 | $1.7M | $301104 | $2.9M | $1.9M | $1.4M | $3.3M |
| Deuda a Corto | 0 | 0 | $2.6M | $4.2M | $12.7M | $4.3M | $854697 | $301660 | $306708 |
| Pasivos Corrientes | $156239 | $437886 | $7.3M | $7.0M | $16.5M | $9.5M | $3.3M | $2.2M | $4.6M |
| Deuda a Largo | 0 | 0 | 0 | 0 | $4.4M | $140148 | 0 | 0 | 0 |
| Pasivos Totales | $7.2M | $7.4M | $7.3M | $7.0M | $24.6M | $9.9M | $3.4M | $2.2M | $4.6M |
| Reservas | -$31193 | $2.1M | -$56.0M | -$56.0M | -$85.8M | -$110.9M | -$121.6M | -$129.5M | -$139.7M |
| Patrimonio Neto | $195.3M | $197.4M | -$6.7M | -$6.4M | -$7.9M | -$3.7M | -$322858 | $3.7M | $3.2M |
| Deuda Total | 0 | 0 | $2.6M | $4.3M | $17.2M | $4.4M | $854697 | $301660 | $306708 |
| Deuda Neta | -$2.1M | -$1.7M | $2.3M | $4.1M | $4.9M | $1.3M | -$268907 | -$3.2M | -$4.0M |
| Capital Circulante | $2.2M | $1.5M | -$6.7M | -$6.7M | -$819073 | -$4.2M | -$1.0M | $3.1M | $2.7M |
Flujo de Caja (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$31193 | -$1.3M | $365954 | -$160875 | -$29.1M | -$24.2M | -$10.6M | -$8.0M | -$10.2M |
| Amortizaciones | 0 | 0 | 0 | $201 | $151 | 0 | 0 | 0 | $6533 |
| Compensación en Acciones | 0 | 0 | 0 | $178679 | $121764 | $1.1M | $879160 | $110723 | $177086 |
| Cambio en Capital Circulante | -$101501 | $273129 | $2.5M | $185103 | -$1.3M | $5.5M | -$947079 | -$851249 | $1.5M |
| Flujo de Caja Operativo | -$251831 | -$1.2M | $11.0M | -$1.2M | -$8.2M | -$17.9M | -$10.8M | -$7.5M | -$7.8M |
| Inversiones (CapEx) | 0 | 0 | $4 | 0 | 0 | 0 | 0 | 0 | -$123643 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | -$11.6M | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$251831 | -$1.2M | $11.0M | -$1.2M | -$8.2M | -$17.9M | -$10.8M | -$7.5M | -$7.9M |
Crecimiento y Márgenes (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | -100.0% | ||||||||
| Crecimiento Beneficio Neto (anual) | -4205.5% | -652.2% | +100.6% | -51330.8% | +16.9% | +56.1% | +24.7% | -27.4% | |
| Crecimiento BPA (anual) | -4130.8% | -654.5% | +133.7% | -63614.3% | +60.8% | +96.6% | +2.6% | +12.9% | |
| Cambio en Acciones (anual) | +0.4% | +1.4% | +4.5% | -98.7% | +114.2% | +1158.3% | -22.8% | +1363.9% | |
| Crecimiento FCF (anual) | -391.7% | +987.9% | -111.3% | -560.8% | -117.0% | +39.7% | +30.4% | -5.7% | |
| Margen Bruto | -92.9% | ||||||||
| Margen Operativo | -485.7% | ||||||||
| Margen EBITDA | -485.7% | ||||||||
| Margen Neto | -572.7% | ||||||||
| Margen FCF | 623.3% | ||||||||
| Tasa Impositiva Efectiva | -13.2% | 20.7% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-0.04 | $-0.21 | $1.81 | $-0.20 | $-98.10 | $-99.41 | $-4.76 | $-4.29 | $-0.31 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $6.0M | $6.0M | $6.1M | $4.5M | $84018 | $179932 | $2.3M | $1.7M | $2.6M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -316.63% |
| Rentabilidad sobre capital invertido | -320.89% |
| Rentabilidad sobre activos | -136.54% |
| Margen bruto | 100.00% |
| Margen operativo | -1087.47% |
| Margen neto | -1084.23% |
Salud financiera
| Deuda / Patrimonio | -0.25 |
| Ratio corriente | 0.70 |
| Piotroski F-Score | 0 |
| Altman Z-Score | -29.36 |
Ratios Clave (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| P/E | -6611538.46 | -160690.91 | -22597.59 | 79937.36 | -47.57 | -0.97 | -3.39 | -1.78 | -0.23 |
| P/VC | 1053.57 | 1075.65 | -34223.64 | -30984.03 | -180.44 | -6.54 | -111.50 | 3.83 | 0.73 |
| P/V | 0.00 | 0.00 | 129529.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | -92.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | -485.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | -572.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Empresas relacionadas: AIM · CANF · KALA · KZIA · OGEN · QLGN · SNGX
Explorar sector: Healthcare · Biotechnology
Más secciones de ENSC: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones